pentoxifylline has been researched along with Cancer of Pelvis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thirteen serious adverse events occurred." | 3.11 | Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study. ( Abdi, BA; Abraham, D; Adams, C; Anbalagan, S; Andreyev, HJN; Bliss, J; Boyle, S; Gothard, L; Hauer-Jensen, M; Lucy, C; Matthews, J; Musallam, A; Taylor, A; Tovey, H; Yarnold, J, 2022) |
| "Radiation-induced tissue fibrosis is a common adverse effect of curative treatment for pelvic cancer." | 2.71 | Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. ( Brooker, S; Cornes, P; Earl, J; Glees, J; Gothard, L; Hall, E; Peckitt, C; Tait, D; Yarnold, J, 2005) |
| "Radiation enteritis is a severe problem in patients receiving irradiation of the abdomen or pelvis in the course of cancer treatment." | 2.44 | Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review. ( Böcker, U; Singer, MV; Wenz, F; Zimmerer, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andreyev, HJN | 1 |
| Matthews, J | 1 |
| Adams, C | 1 |
| Gothard, L | 2 |
| Lucy, C | 1 |
| Tovey, H | 1 |
| Boyle, S | 1 |
| Anbalagan, S | 1 |
| Musallam, A | 1 |
| Yarnold, J | 2 |
| Abraham, D | 1 |
| Bliss, J | 1 |
| Abdi, BA | 1 |
| Taylor, A | 1 |
| Hauer-Jensen, M | 1 |
| Cornes, P | 1 |
| Brooker, S | 1 |
| Earl, J | 1 |
| Glees, J | 1 |
| Hall, E | 1 |
| Peckitt, C | 1 |
| Tait, D | 1 |
| Zimmerer, T | 1 |
| Böcker, U | 1 |
| Wenz, F | 1 |
| Singer, MV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomised Double-blind Placebo Controlled Phase II Trial of Tocovid SupraBio in Combination With Pentoxifylline (PTX) in Patients Suffering Long-term Adverse Effects of Radiotherapy for Pelvic Cancer[NCT02230800] | Phase 2 | 62 participants (Actual) | Interventional | 2014-11-25 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pentoxifylline and Cancer of Pelvis
| Article | Year |
|---|---|
Medical prevention and treatment of acute and chronic radiation induced enteritis--is there any proven therapy? a short review.
Topics: Abdominal Neoplasms; Acute Disease; Chronic Disease; Combined Modality Therapy; Controlled Clinical | 2008 |
2 trials available for pentoxifylline and Cancer of Pelvis
| Article | Year |
|---|---|
Randomised single centre double-blind placebo controlled phase II trial of Tocovid SupraBio in combination with pentoxifylline in patients suffering long-term gastrointestinal adverse effects of radiotherapy for pelvic cancer: The PPALM study.
Topics: Double-Blind Method; Humans; Male; Pelvic Neoplasms; Pentoxifylline; Quality of Life; Tocotrienols; | 2022 |
Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Patie | 2005 |